Navigation Links
Ikaria Strengthens Executive Leadership Team
Date:10/2/2008

- Head of Engineering and Operations Appointed -

CLINTON, N.J., Oct. 2 /PRNewswire/ -- Ikaria Holdings, Inc. today announced the appointment of Michael Kennedy as Senior Vice President, Engineering and Operations. In this role, Kennedy will be responsible for drug-device technology strategy and development.

"Michael's extensive experience will help Ikaria strengthen its leadership in critical care as we continue to advance our pharmaceutical pipeline through a number of strategies including our strong commitment to drug-device development," said Daniel Tasse', President and CEO of Ikaria. "I am pleased to welcome Michael, who will complete our executive leadership team."

Most recently, Kennedy served as Vice President, Technology Platform Development in the Pharmaceutical and Technology Division of Baxter International Inc., where he led drug-device technology strategy and development across the organization's portfolio. Previously he led the global development of Baxter's industry-leading dialysis and transfusion therapy innovations. Kennedy's executive experience also includes senior positions at General Electric, Hollister Inc. and Comdisco Healthcare Group.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceuticals, biologic messengers and drug-device combinations for hospitalized, critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Australia and Latin America. INOmax recently was approved for marketing in Japan. Ikaria is engaged in new and ongoing clinical development of INOmax, Covox(R) (carbon monoxide) for inhalation and hydrogen sulfide. Ikaria is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI, and a manufacturing facility in Port Allen, LA. For more information, please visit http://www.ikaria.com.

CONTACT:

Samina Bari

Ikaria

(908) 238-6372

samina.bari@ikaria.com


'/>"/>
SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
2. Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine
3. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
4. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
5. Ikaria to Present at 26th Annual JPMorgan Healthcare Conference
6. Ikaria Founding Scientist Named 2007 MacArthur Fellow
7. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
8. Algenol Biofuels Further Strengthens Team With Key Appointments
9. InNexus Biotechnology Strengthens Patent Team With New Leadership
10. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
11. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... Lexington, Massachusetts (PRWEB) , ... June 16, 2017 ... ... in medical device compliance and commercialization, has just announced two more sessions of ... of the series will focus on the world of online templates for design ...
(Date:6/16/2017)... CT (PRWEB) , ... June 16, 2017 , ... ... night’s Entrepreneur Innovation Awards (EIA), held at The LOFT at Chelsea Piers in Stamford. ... project ideas to a panel of judges for an opportunity to secure $10,000 awards ...
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa Therapeutics, a ... round of financing in the amount of $6 million. An investment vehicle affiliated ... the round. , The Series B funding will enable Cybrexa to complete the ...
(Date:6/15/2017)... (PRWEB) , ... June 15, 2017 , ... ... Saranas, a promising new medical device startup. Dan Parsley, angelMD’s SVP of Corporate ... angelMD members, and this angelMD syndicate is part of Saranas’ recently announced $4 ...
Breaking Biology Technology:
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):